SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
bluebird bio Inc.
An SI Board Since November 2013
Posts SubjectMarks Bans Symbol
163 36 0 BLUE
Emcee:  Biotech Jim Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
163statnews.com "FDA advisers unanimously endorse Bluebird’s gene therapy forscaram(o)uche-6/9/2022
162Every time juno gets a kick, blue rides along. But this is (likely) juno's scaram(o)uche-1/22/2018
161Bad judgement, just bad. Let the principal investigator discuss the work. Dramscaram(o)uche-11/1/2017
160BLUE up 22% after hours on positive trial data for CAR-T candidate bb2121 BluebiJulius Wong-11/30/2016
159The U.S. Food and Drug Administration is allowing Bluebird to treat beta thalassscaram(o)uche-9/8/2016
158Small biotech Global Blood Therapeutics ( GBT) soared in heavy trading on the stThe Ox-6/10/2016
157stockcharts.com [graphic] [graphic]The Ox-6/9/2016
156Bluebird bio's gene therapy candidate for rare X chromosome-linked disorder Julius Wong14/20/2016
155>> and cmrx << Been looking for that post. Nice timing. ;-( Thinscaram(o)uche-1/11/2016
154Back in at 44 with a token position. Token = 2% of my former position, speakingscaram(o)uche-1/11/2016
153Anyway, it was a good thought and it appears that market-in-general looked for ascaram(o)uche-12/16/2015
152chuckle -- i hesitated...would have been a nice scalp indeed. still keeping an mopgcw-12/16/2015
151That was 20% upside in a few days, hope you pulled trigger and sorry I wasn'scaram(o)uche-12/16/2015
150Now for an on topic post... I must apologize to readers of this board for my laBiotech Jim112/9/2015
149I like that FierceBiotech is calling the IV formulation the "liquid versionBiotech Jim-12/9/2015
148O.T. re. cara...... siliconinvestor.comscaram(o)uche-12/9/2015
147Biotech Jim and just plain Jim. ;-)scaram(o)uche-12/9/2015
146Cara up huge premkt. Nice!Robohogs-12/9/2015
145Hey, George. Price to book has (un)grown to appealing, but, no, I'm not. Rscaram(o)uche-12/8/2015
144getting crushed. started poking around. you buying here?mopgcw-12/7/2015
143ASH thoughts, Dan Marks..... biotechr.comscaram(o)uche-12/4/2015
1428:24 am Bluebirdbio sells off after updating data abstracts at ASH; two B0/B0 geJulius Wong-11/5/2015
141Biotech Stock Mailbag: New Sarepta Risk, Zafgen Patient Death, Bluebird Gene TheJulius Wong-10/19/2015
140>> Following approximately seven years of transfusion independence, subjecscaram(o)uche-10/19/2015
139To many, this has been biotech's darling..... over-valued. Today marked scaram(o)uche-9/25/2015
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News